Published in Pediatr Nephrol on June 05, 2013
Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract. PLoS One (2013) 0.90
The nature of immune responses to urinary tract infections. Nat Rev Immunol (2015) 0.86
An endogenous ribonuclease inhibitor regulates the antimicrobial activity of ribonuclease 7 in the human urinary tract. Kidney Int (2013) 0.86
Ribonucleases 6 and 7 have antimicrobial function in the human and murine urinary tract. Kidney Int (2014) 0.86
The diagnosis, evaluation and treatment of acute and recurrent pediatric urinary tract infections. Expert Rev Anti Infect Ther (2014) 0.85
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83
Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Rev Clin Immunol (2014) 0.83
Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis. Nat Rev Nephrol (2015) 0.80
A Prospective, Observational Pilot Study of the Use of Urinary Antimicrobial Peptides in Diagnosing Emergency Department Patients With Positive Urine Cultures. Acad Emerg Med (2015) 0.79
Expression and Significance of the HIP/PAP and RegIIIγ Antimicrobial Peptides during Mammalian Urinary Tract Infection. PLoS One (2015) 0.78
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Evaluation of novel urinary tract infection biomarkers in children. Pediatr Res (2016) 0.75
The multiple antibacterial activities of the bladder epithelium. Ann Transl Med (2017) 0.75
Immunologists' perspective of nephropathology. J Nephropathol (2016) 0.75
Immunity to uropathogens: the emerging roles of inflammasomes. Nat Rev Urol (2017) 0.75
The role of toll-like receptors (TLRs) in urinary tract infections (UTIs). Cent European J Urol (2016) 0.75
Genetic Variations in Vesicoureteral Reflux Sequelae. Pathogens (2016) 0.75
The Genetics of Urinary Tract Infections and the Innate Defense of the Kidney and Urinary tract. J Pediatr Genet (2015) 0.75
Polymorphisms in α-Defensin-Encoding DEFA1A3 Associate with Urinary Tract Infection Risk in Children with Vesicoureteral Reflux. J Am Soc Nephrol (2016) 0.75
Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract. Kidney Int (2016) 0.75
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem (2000) 8.39
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev (2003) 6.57
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood (2002) 3.93
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A (2000) 2.98
Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol (2012) 2.75
Urine as a medium for bacterial growth. Lancet (1966) 2.46
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1. Nature (2011) 2.31
Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe (2008) 2.26
Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis (1999) 2.23
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol (1998) 2.19
Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect Immun (1978) 2.13
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun (2005) 2.10
RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem (2002) 1.99
Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics (2005) 1.97
Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis (1997) 1.87
The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. Genomics (1997) 1.86
Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract. Kidney Int (2013) 1.81
Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry (2009) 1.72
Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol (2007) 1.59
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol (2007) 1.57
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med (2000) 1.57
Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. J Am Chem Soc (2009) 1.53
Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract. Cell Microbiol (2001) 1.50
Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun (2002) 1.49
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun (2004) 1.48
Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children. J Urol (2005) 1.46
Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics (2001) 1.44
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun (2005) 1.41
Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics (2008) 1.33
Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest (2008) 1.32
Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol (2006) 1.32
Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis (2003) 1.30
The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem (2006) 1.29
Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis (2007) 1.26
Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett (1998) 1.26
Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int (2011) 1.25
Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun (2006) 1.23
Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis (2002) 1.20
TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest (2008) 1.15
Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis (2007) 1.15
Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J (2011) 1.12
Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J Biol Chem (2008) 1.12
Innate and adaptive immune responses in the urinary tract. Eur J Clin Invest (2008) 1.10
The unstable bladder: towards a common mechanism. Br J Urol (1994) 1.10
Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS One (2012) 1.08
Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol Biosyst (2007) 1.06
Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans (2006) 1.06
Sepsis induces an increase in thick ascending limb Cox-2 that is TLR4 dependent. Am J Physiol Renal Physiol (2007) 1.05
May we go on with antibacterial prophylaxis for urinary tract infections? Pediatr Nephrol (2005) 1.04
Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys. Infect Immun (1987) 1.03
Kidney dendritic cells induce innate immunity against bacterial pyelonephritis. J Am Soc Nephrol (2011) 1.02
TLR-mediated immune responses in the urinary tract. Curr Opin Microbiol (2008) 1.00
Pathogenesis of urinary tract infection. Role of host defenses. Infect Dis Clin North Am (1997) 0.97
Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections. Pediatr Nephrol (2012) 0.96
Defensin-barbed innate immunity: clinical associations in the pediatric population. Pediatrics (2010) 0.96
Maintaining a sterile urinary tract: the role of antimicrobial peptides. J Urol (2009) 0.95
Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA. Pediatr Nephrol (2010) 0.91
Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One (2011) 0.91
Congenital immunodeficiencies in mice increase susceptibility to urinary tract infection. J Urol (1993) 0.91
Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes Immun (2004) 0.89
A role for collecting duct epithelial cells in renal antibacterial defences. Cell Microbiol (2011) 0.88
Tolerance of bacteriuria after urinary diversion is linked to antimicrobial peptide activity. Urology (2010) 0.88
Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria. Antimicrob Agents Chemother (2012) 0.87
Novel distribution of the secretory leucocyte proteinase inhibitor in kidney. Mediators Inflamm (2001) 0.87
Genetic polymorphisms and susceptibility to parenchymal renal infection among pediatric patients. Pediatr Infect Dis J (2011) 0.86
A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant (1997) 0.86
Genetic risk for recurrent urinary tract infections in humans: a systematic review. J Biomed Biotechnol (2010) 0.85
Host parasite interaction in urinary tract infection. Pediatr Nephrol (1987) 0.82
Impact of Toll-like receptor signalling on urinary tract infection. Int J Antimicrob Agents (2007) 0.81
Upper urinary tract infections are associated with RANTES promoter polymorphism. J Pediatr (2010) 0.78
Quantitation of urinary Tamm-Horsfall protein in children with urinary tract infection. Eur Urol (1992) 0.76
Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med (2006) 3.29
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J Clin Invest (2006) 3.27
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity (2005) 3.14
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity (2010) 2.67
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet (2005) 2.63
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity (2006) 2.56
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood (2010) 2.41
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood (2009) 2.18
Ribonuclease 7, an antimicrobial peptide upregulated during infection, contributes to microbial defense of the human urinary tract. Kidney Int (2013) 1.81
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood (2004) 1.73
Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res (2005) 1.69
Urine risk factors in children with calcium kidney stones and their siblings. Kidney Int (2012) 1.52
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood (2004) 1.39
Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int (2011) 1.25
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics (2004) 1.20
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci U S A (2007) 1.19
The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest (2003) 1.17
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. J Exp Med (2007) 1.15
Deletion of Frs2alpha from the ureteric epithelium causes renal hypoplasia. Am J Physiol Renal Physiol (2009) 1.12
PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J Immunol (2010) 1.11
Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS One (2012) 1.08
Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. Clin Cancer Res (2002) 1.00
Management and etiology of the unilateral multicystic dysplastic kidney: a review. Pediatr Nephrol (2008) 0.97
STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur J Immunol (2006) 0.96
Transcriptional control of human T-BET expression: the role of Sp1. Eur J Immunol (2007) 0.96
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood (2008) 0.94
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood (2006) 0.93
Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA. Pediatr Nephrol (2010) 0.91
Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract. PLoS One (2013) 0.90
Novel X-linked glomerulopathy is associated with a COL4A5 missense mutation in a non-collagenous interruption. Kidney Int (2010) 0.89
Ultrasound imaging of the murine kidney. Methods Mol Biol (2012) 0.89
Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer (2010) 0.88
New directions in natural killer cell-based immunotherapy of human cancer. Expert Opin Biol Ther (2003) 0.87
Contribution of structural domains to the activity of ribonuclease 7 against uropathogenic bacteria. Antimicrob Agents Chemother (2012) 0.87
Molecular basis of renal adaptation in a murine model of congenital obstructive nephropathy. PLoS One (2013) 0.85
Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation. J Immunol (2006) 0.85
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leuk Res (2009) 0.84
Increasing frequency of acute kidney injury amongst children hospitalized with nephrotic syndrome. Pediatr Nephrol (2013) 0.83
Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden. Pediatr Nephrol (2014) 0.82
The demographics and costs of inpatient vesicoureteral reflux management in the USA. Pediatr Nephrol (2011) 0.82
The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection. J Pediatr Urol (2010) 0.82
Trends in hospitalization characteristics for pediatric nephrotic syndrome in the USA. Clin Nephrol (2012) 0.80
Struvite urolithiasis and chronic urinary tract infection in a murine model of urinary diversion. Urology (2013) 0.80
Urinary diversion via cutaneous vesicostomy in the megabladder mouse. Methods Mol Biol (2012) 0.80
Impact of urinary tract infection on inpatient healthcare for congenital obstructive uropathy. J Pediatr Urol (2011) 0.80
Bacterial differentiation, development, and disease: mechanisms for survival. FEMS Microbiol Lett (2014) 0.80
The effects of hypertension on cognitive function in children and adolescents. Int J Pediatr (2012) 0.78
Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. PLoS One (2013) 0.77
Kidney transplantation in the United States: economic burden and recent trends analysis. Prog Transplant (2013) 0.77
Hepatoblastoma and prune belly syndrome: a potential association. Pediatr Nephrol (2011) 0.77
Continuous infusion of a standard combination solution in the management of hyperkalemia. Nephrol Dial Transplant (2011) 0.77
A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient. Pediatr Transplant (2011) 0.76
Cancer T cell therapy expands. Nat Med (2003) 0.75
A descriptive analysis of public school educators arrested for sex offenses. J Child Sex Abus (2014) 0.75
Testing for Urinary Tract Infection in the Influenza/Respiratory Syncytial Virus-Positive Febrile Infant Aged 2 to 12 Months. Pediatr Emerg Care (2017) 0.75
Treatment of intractable rectal stump drainage with cryoablation. Am J Gastroenterol (2012) 0.75